| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 10/12/2004 | US6803448 GBS toxin receptor |
| 10/12/2004 | US6803358 Ricin-like toxin variants for treatment of cancer, viral or parasitic infections |
| 10/12/2004 | US6803232 Neuropeptide y (npy) receptor (designated npy- y7) used to express the receptor in cells which can then be used for drug screening |
| 10/12/2004 | US6803231 Method of delivering antigens for vaccination with a live vector |
| 10/12/2004 | US6803225 Expression vector for use transformation of yeast cells |
| 10/12/2004 | US6803214 Nucleic acids and new polypeptides associated with and/or overlapping with hepatitis C virus core gene products |
| 10/12/2004 | US6803213 Having one or more amino acid substitutions that confer receptor agonist or antagonist properties |
| 10/12/2004 | US6803212 Low oxygen affinity mutant hemoglobins |
| 10/12/2004 | US6803211 Cancer therapy |
| 10/12/2004 | US6803199 Thyroid sodium/iodide symporter and nucleic acid encoding same |
| 10/12/2004 | US6803192 B7-H1, a novel immunoregulatory molecule |
| 10/12/2004 | US6803188 Tandem fluorescent protein constructs |
| 10/12/2004 | US6803186 Compositions and methods for increasing amino acid absorption in mammals |
| 10/12/2004 | US6803184 MPR-related ABC transporter encoding nucleic acids and methods of use thereof |
| 10/12/2004 | US6803043 Basbo27 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses |
| 10/12/2004 | CA2387401C Compositions, methods and systems for the production of enediynes |
| 10/12/2004 | CA2110585C Therapeutic fragments of von willebrand factor |
| 10/12/2004 | CA1341458C Modified human t-pa |
| 10/11/2004 | CA2461106A1 Compositions and methods for genetic analysis of polycystic kidney disease |
| 10/07/2004 | WO2004086052A2 Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor adenosine a2b (adora2b) |
| 10/07/2004 | WO2004086039A2 A method for modulating nod1 activity, use of a mtp related molecule for modulating nod1 activity, and therapeutic applications thereof |
| 10/07/2004 | WO2004085683A2 Method for early carcinoma detection and a test kit for carrying our said method |
| 10/07/2004 | WO2004085682A2 Caspase inhibitors, especially caspase 3 inhibitors, for the treatment of influenza |
| 10/07/2004 | WO2004085674A1 Methods for the diagnosis and treatment of epilepsy |
| 10/07/2004 | WO2004085666A2 Secreted proteins |
| 10/07/2004 | WO2004085664A2 Process for the preparation of angiotensin converting enzyme (ace) inhibitors and its use |
| 10/07/2004 | WO2004085660A2 Improved alphavirus replicons and helper constructs |
| 10/07/2004 | WO2004085659A2 Mutant vesicular stomatitis viruses and uses thereof |
| 10/07/2004 | WO2004085658A1 Mutant vesicular stomatitis viruses and use thereof |
| 10/07/2004 | WO2004085653A1 Cell death-inducing fused gene acting specifically on cancer and gene product thereof |
| 10/07/2004 | WO2004085649A1 Prfb factor (peptide chain release factor b) from bacillus licheniformis and the utilization thereof for enhancing the protein formation rate |
| 10/07/2004 | WO2004085648A2 Nogo receptor binding protein |
| 10/07/2004 | WO2004085647A1 Low-molecular weight peptides inhibiting ion channel activity |
| 10/07/2004 | WO2004085646A1 Cyclic amp response element activator proteins and uses related thereto |
| 10/07/2004 | WO2004085644A2 Method for producing recombinant organisms |
| 10/07/2004 | WO2004085642A1 Arthritis-associated gene and use thereof in examining arthritis |
| 10/07/2004 | WO2004085635A1 Melan-a peptide analogue-virus-like-particle conjugates |
| 10/07/2004 | WO2004085634A2 Infectious bursal disease virus mutants and vaccines |
| 10/07/2004 | WO2004085625A2 Proteins associated with cell growth, differentiation, and death |
| 10/07/2004 | WO2004085621A2 Gene expression in breast cancer |
| 10/07/2004 | WO2004085617A2 Timp3 as vegf inhibitor |
| 10/07/2004 | WO2004085616A2 Regulation of self-renewal in stem cells |
| 10/07/2004 | WO2004085612A2 Metal binding proteins |
| 10/07/2004 | WO2004085505A2 Long acting biologically active conjugates |
| 10/07/2004 | WO2004085479A2 Treatment of viral infections |
| 10/07/2004 | WO2004085478A2 Improved fc fusion proteins |
| 10/07/2004 | WO2004085476A2 Anti-il-22ra antibodies and binding partners and methods of using in inflammation |
| 10/07/2004 | WO2004085475A2 Anti-il-20 antibodies and binding partners and methods of using in inflammation |
| 10/07/2004 | WO2004085473A2 Rgd-enriched gelatine-like proteins with enhanced cell binding |
| 10/07/2004 | WO2004085472A1 Method for making human insulin precursors and human insulin |
| 10/07/2004 | WO2004085471A2 Glp-2 derivatives |
| 10/07/2004 | WO2004085470A1 Interferon-alpha induced gene |
| 10/07/2004 | WO2004085469A2 Secreted protein family |
| 10/07/2004 | WO2004085468A2 Human p53 splice variant displaying differential transcriptional activity |
| 10/07/2004 | WO2004085467A1 Process for isolating haemocyanin |
| 10/07/2004 | WO2004085466A2 Immunogenic hiv-1 multi-clade, multivalent constructs and methods of their use |
| 10/07/2004 | WO2004085464A2 Ph-dependent polypeptide aggregation and its use |
| 10/07/2004 | WO2004085461A2 Tumour-associated peptides binding to mhc molecules |
| 10/07/2004 | WO2004085272A1 Lock for a flat and low pourer provided with a removable element in the form of a laminate of film for a composite package for container openings closed by a nonpermeable film |
| 10/07/2004 | WO2004084965A2 Improved osteoinductive materials |
| 10/07/2004 | WO2004084945A1 Eating controllers |
| 10/07/2004 | WO2004084942A2 Methods and means to suppress symptoms of an allergic disease by inhibiting the glucocorticoid-induced tumor necrosis factor receptor (gitr or tnfrsf18) |
| 10/07/2004 | WO2004084940A1 Packaging of immunostimulatory oligonucleotides into virus-like particles: method of preparation and use |
| 10/07/2004 | WO2004084939A2 Hiv-peptide-carrier-conjugates |
| 10/07/2004 | WO2004084938A1 Improved vaccines |
| 10/07/2004 | WO2004084937A1 Use of alum and a th1 immune response inducing adjuvant for enhancing immune responses |
| 10/07/2004 | WO2004084930A1 Use of saposin-related proteins for preventing and treating obesity, diabetes and/or metabolic syndrome |
| 10/07/2004 | WO2004084831A2 Optimized expression of hpv 31 l1 in yeast |
| 10/07/2004 | WO2004084814A2 High viscosity xanthan polymer preparations |
| 10/07/2004 | WO2004084811A2 Crystals and structures of epidermal growth factor receptor kinase domain |
| 10/07/2004 | WO2004084810A2 Novel imidazoline receptor homologs |
| 10/07/2004 | WO2004084806A2 Protein modification and maintenance molecules |
| 10/07/2004 | WO2004084805A2 Acetylated tat polypeptides and methods of use thereof |
| 10/07/2004 | WO2004084800A2 A3 receptor-mediated cardioprotective proteins and therapeutic and diagnostic methods of use |
| 10/07/2004 | WO2004084797A2 Type 2 diabetes mellitus-associated gene and utilization of the same |
| 10/07/2004 | WO2004084711A2 Methods of detecting neurological disorders |
| 10/07/2004 | WO2004074432A9 Antibody vaccine conjugates and uses therefor |
| 10/07/2004 | WO2004069997A3 Method for the production of a composition of dna sequences or the expression products thereof permitting the identification of the strains of helicobacter pylori and use thereof in a prognostic or diagnostic method |
| 10/07/2004 | WO2004069873A3 Antigen/antibody or ligand/receptor glycosylated specificity exchangers |
| 10/07/2004 | WO2004067698A3 Helminth-derived antigens having capacity of providing protection against parasites |
| 10/07/2004 | WO2004067549A3 Peptides directed against antibodies, which cause cold-intolerance, and the use thereof |
| 10/07/2004 | WO2004067030A3 Injectable vaccines against multiple meningococcal serogroups |
| 10/07/2004 | WO2004064714A3 Animal model for obesity independently of insulin resistance |
| 10/07/2004 | WO2004056852A3 Cyanovirin variant-polymer conjugates |
| 10/07/2004 | WO2004050881A3 A plant transcription factor that is involved in sugar signalling |
| 10/07/2004 | WO2004048402B1 A hepatitis c virus codon optimized non-structural ns3/4a fusion gene |
| 10/07/2004 | WO2004046319A3 Bacteriophage having modified holin and uses thereof |
| 10/07/2004 | WO2004044159A3 Receptors and membrane-associated proteins |
| 10/07/2004 | WO2004043995A3 Process for the preparation of glatiramer acetate by polymerisation of n-carboxy anhydrides of l-alanine, l-tyrosine, benzyl l-glutamate and benzyloxycarbonyl l-lysine |
| 10/07/2004 | WO2004042035A3 Organic anion transport polypeptide related protein-4 (oatprp4) gene in tourette syndrome and related disorders |
| 10/07/2004 | WO2004040262A8 Compositions and methods for modifying toxic effects of proteinaceous compounds |
| 10/07/2004 | WO2004038375A3 Water soluble toxin produced by pfiesteria species |
| 10/07/2004 | WO2004035626A3 Alpha macroglobulin protein family members |
| 10/07/2004 | WO2004035612A3 Composition, method and use of bi-functional biomaterials |
| 10/07/2004 | WO2004033661A3 Ferritin light subunit variant-encoding nucleic acids, polypeptides, transgenic animals, antibodies, and methods of use thereof |
| 10/07/2004 | WO2004030616A3 Ii-KEY/ANTIGENIC EPITOPE HYBRID PEPTIDE VACCINES |
| 10/07/2004 | WO2004029206A3 Targeted cd1d molecules |
| 10/07/2004 | WO2004024880A3 AMPDs AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE |
| 10/07/2004 | WO2004018636A3 Methods for modulating transcriptional activation using mint proteins |
| 10/07/2004 | WO2004018629A3 Stars-a muscle-specification-binding protein |